Nanomechanical testing: Challenges and opportunities
نویسندگان
چکیده
منابع مشابه
Islam; Challenges and Opportunities
Undoubtedly Islamic Revolution of Iran has been the source of Islamic awakening in the middle-east. Therefore Islamic Republic of Iran plays the role of an example and a director of political developments in the region. Islamic awakening in Arab countries has been able to question the dominant discourse of dictators in the middle-east region and topple their regimes. These developments include ...
متن کاملInduced Pluripotent Stem Cells: Challenges and Opportunities
Regenerative capacity of mammals is limited and can rarely regenerate a specific organ or tissue fully. Due to these limitations, regenerative medicine seeks efficient and safe cell sources for regeneration of damaged tissues and organs or treatment for incurable diseases. Human embryonic stem cells (HESCs) hold two important properties called self renewal and pluripotency. However, the use of ...
متن کاملPersian Asafoetida vs. Sagapenum: Challenges and Opportunities
Asafoetida and sagapenum as valuable Iranian oleo-gum-resins from Ferula spp. (F. assa-foetida, F. persica, F. foetida and F. alliacea) have received interest during the history for producing valuable perfumes and common spices or as pharmaceutical agents. The aim of the present work was to characterize sources of asafoetida and sagapenum, according ...
متن کاملTesting for HIV/STIs in China: Challenges, Opportunities, and Innovations
1Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China 2Kirby Institute, The University of New South Wales, Sydney, NSW 2052, Australia 3Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC 3053, Australia 4Central Clinical School, Monash University, Melbourne, VIC 3004, Australia 5School of Public Health and Prevent...
متن کاملHER2 Testing in Breast Cancer: Opportunities and Challenges
Zusammenfassung Der humane epidermale Wachstumsfaktor-Rezeptor-2 (HER2) wird in 15–25% der Mammakarzinome überexprimiert, üblicherweise auf dem Boden einer Genamplifikation. Ein positiver HER2-Status gilt als ungünstiger Prognosefaktor. Die Aufdeckung der Rolle von HER2 im Tumorwachstum des Mammakarzinoms hat zu der Entwicklung einer anti-HER2-gerichteten Therapie geführt. Der humanisierte mono...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOM
سال: 2009
ISSN: 1047-4838,1543-1851
DOI: 10.1007/s11837-009-0173-9